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Abstract
Equine arteritis virus (EAV) infects endothelial cells (ECs) and macrophages in horses, and many of the clinical manifestations of equine
viral arteritis (EVA) reflect vascular injury. To further evaluate the potential role of EAV-induced, macrophage-derived cytokines in the
pathogenesis of EVA, we infected cultured equine alveolar macrophages (AM), blood monocyte-derived macrophages (BM), and
pulmonary artery ECs with either a virulent (KY84) or an avirulent (CA95) strain of EAV. EAV infection of equine AM, BM, and ECs
resulted in their activation with increased transcription of genes encoding proinflammatory mediators, including interleukin (IL)-1, IL-6,
IL-8, and tumor necrosis factor (TNF)-. Furthermore, the virulent KY84 strain of EAV induced significantly higher levels of mRNA
encoding proinflammatory cytokines in infected AM and BM than did the avirulent CA95 strain. Treatment of equine ECs with the
culture supernatants of EAV-infected AM and BM also resulted in EC activation with cell surface expression of E-selectin, whereas
infection of ECs with purified EAV alone caused only minimal expression of E-selectin. The presence of TNF- in the culture supernatants
of EAV-infected equine AM, BM, and ECs was confirmed by bioassay, and the virulent KY84 strain of EAV induced significantly more
TNF- in all cell types than did the avirulent CA95 strain. Thus, the data indicate that EAV-induced, macrophage-derived cytokines may
contribute to the pathogenesis of EVA in horses, and that the magnitude of the cytokine response of equine AM, BM, and ECs to EAV
infection reflects the virulence of the infecting virus strain.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Equine arteritis virus (EAV) is the causative agent of
equine viral arteritis (EVA). EAV infection can cause in-
fluenza-like respiratory disease in adult horses, abortion of
pregnant mares, interstitial pneumonia in young foals, and
persistent infection in stallions (Glaser et al., 1996;
Timoney and McCollum, 1993; Timoney et al., 1987). EAV
is transmitted horizontally either by aerosol respiratory in-
fection of susceptible horses or by natural or artificial breed-
ing of mares to persistently infected, EAV-shedding stal-
lions (Glaser et al., 1996; Timoney et al., 1986, 1987). EAV
is the prototype virus in the family Arteriviridae (genus
Arterivirus) in the order Nidovirales, a grouping that also
includes lactate dehydrogenase elevating virus (LDV) of
mice, simian hemorrhagic fever virus (SHV), and porcine
reproductive and respiratory syndrome virus (PRRSV; Ca-
vanagh, 1997). Field isolates of EAV vary significantly in
their virulence; whereas infection of adult horses with some
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strains of EAV results in disease of varying severity, most
virus strains cause only subclinical or asymptomatic infec-
tion (McCollum and Timoney, 1999; Patton et al., 1999;
Timoney and McCollum, 1993).
Many of the clinical manifestation of EVA reflect vas-
cular injury. Severe EVA is characterized by panvasculitis
with necrosis and leukocytic infiltration of medium and
small muscular arteries (Crawford and Henson, 1973; Estes
and Cheville, 1970; Jones et al., 1957; MacLachlan et al.,
1996). Furthermore, we recently have shown that the
growth characteristics of different strains of EAV in cul-
tured equine ECs are predictive of their virulence to horses
(Moore et al., 2002). Although direct virus-mediated EC
injury is likely to be responsible for many of the manifes-
tations of EVA, EAV also has a strong tropism for macro-
phages (Crawford and Henson, 1973; MacLachlan et al.,
1996; Snijder and Meulenberg, 2001). However, the role of
EAV-induced, macrophage-derived vasoactive and inflam-
matory cytokines in the pathogenesis of EVA is uncharac-
terized.
Macrophages are a primary site of replication for viruses
in the family Arteriviridae (Crawford and Henson, 1973;
Glaser et al., 1996; Murphy et al., 1999; Snijder and Meu-
lenberg, 2001; Timoney and McCollum, 1993). Macro-
phages exist as distinct populations with diverse functional
properties such as cytokine production, response to immu-
noregulatory stimuli, and clearance of pathogens (Ruther-
ford et al., 1993). Alveolar macrophages (AM) are an
essential first line of defense against viral infections of the
lower respiratory tract, and macrophage-derived cytokines
such as interleukin (IL)-1 and tissue necrosis factor
(TNF)- can contribute to the pathogenesis of septic shock
and associated acute lung injury (Kraal et al., 1997; Kobzik,
1999). Similarly, lytic infection of AM contributes to the
acute interstitial pneumonia that occurs in PRRSV-infected
pigs, and predisposes infected pigs to secondary bacterial
pneumonia (Oleksiewicz and Nielsen, 1999). Further,
PRRSV infection of porcine AM inhibits their production
of proinflammatory cytokines such as TNF- (Lopez-
Fuertes et al., 2000). Although it is established that EAV
infects AM after respiratory infection of horses (Crawford
and Henson, 1973; Timoney and McCollum, 1993), the
response of equine AM to EAV infection has not been
characterized either in vitro or in vivo.
The objective of this study was to determine if virus-
induced, macrophage-derived proinflammatory mediators
contribute to the pathogenesis of EVA, specifically, to de-
termine whether EAV infection of equine AM and blood
monocyte-derived macrophages (BM) leads to the produc-
tion of the proinflammatory cytokines TNF-, IL-1, IL-6,
and IL-8, and whether the magnitude of activation of EAV-
infected macrophages and ECs reflects the virulence to
horses of the infecting strain of EAV. Thus, cultured equine
AM and BM were infected with either the virulent KY84
or the avirulent CA95 strain of EAV, and virus replication
and cytokine production were compared at intervals after
infection. Additionally, supernatants from these cultures
then were evaluated for their ability to activate equine ECs.
Results
Replication of virulent and avirulent strains of EAV in
equine macrophages and endothelial cells
Cultured equine macrophages and ECs were infected
with either the virulent KY84 or the avirulent CA95 strains
of EAV to determine their susceptibility. The virulent KY84
strain of EAV replicated to higher titer and caused more
rapid and complete CPE in equine ECs and BM than did
the avirulent CA95 strain (Fig. 1). Specifically, the KY84
strain produced complete CPE in cultured equine ECs by
36 h post-infection (h.p.i.), whereas CPE involved less than
50% of EC monolayers at 72 h.p.i. with CA95. Similarly,
KY84 induced 100% CPE in BM by 24 h.p.i. as compared
to 60 h.p.i. with CA95. Modest increases in virus titer
occurred in BM infected with both virus strains. In con-
trast, titers of EAV decreased over time in cultured AM
Fig. 1. Replication of avirulent (CA95) and virulent (KY84) strains of EAV in equine alveolar macrophages (AM), blood monocyte-derived macrophages
(BM), and endothelial cells (ECs). Cultured equine ECs, AM, and BM were infected with either the CA95 or KY84 strains of EAV at an m.o.i. of 5.0
and virus titers (PFU/ml) were determined in sonicated whole cell lysates at intervals after infection that are shown.
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infected with either the KY84 or the CA95 strain of EAV,
and CPE was never evident in these cultures. These data
clearly demonstrate that cultured equine ECs and BM
support productive replication of both strains of EAV as
evident by viral growth and CPE of the cultured cells,
whereas AM apparently do not.
EAV-induced activation of equine macrophages
Infection with either the KY84 or the CA95 strain of
EAV resulted in activation of equine AM, BM, and ECs,
as determined by the increased transcription of mRNA en-
coding TNF-, IL-1, IL-6, and IL-8 (Fig. 2). Transcription
of all of these genes was detected after infection of AM,
BM, and ECs with both strains of EAV; however, KY84-
infected AM and BM consistently produced higher lev-
els of the various transcripts as compared to CA95-infected
AM and BM. Transcription of TNF-, IL-1, IL-6, and
IL-8 mRNA in KY84-infected AM was significantly
higher than that in CA95-infected AM at all time intervals
(P  0.001). KY84-infected BM also contained signifi-
cantly higher levels of mRNA encoding TNF-, IL-1, and
IL-6 than did CA95-infected BM at 6, 12, and 18 h.p.i. (P
 0.01), and markedly higher levels of IL-8 transcript at all
time points (P  0.001). EAV-infection of ECs also re-
sulted in transcriptional activation of the various cytokine
genes but, with the notable exception of TNF- (P 0.001)
and IL-6 (P 0.001) at 24 h.p.i., the levels of activation did
not differ markedly between KY84- and CA95-infected
ECs.
Secretion of biologically active TNF- from equine ECs,
AM, and BM was confirmed by analysis of culture
supernatants using a bioassay. The KY84 strain of EAV
induced secretion of greater quantities of TNF- from cul-
tured AM (P  0.0001), BM (P  0.0001), and ECs (P
 0.001) at 24 h.p.i. as compared to the amounts detected in
similar cultures infected with the CA95 virus (Fig. 3).
Equine ECs clearly produced TNF-, as determined by both
bioassay and real-time PCR quantitation of mRNA (Figs. 2
and 3).
EAV-infected BM consistently secreted more TNF-
than did EAV-infected AM or ECs at 24 h.p.i. (P 0.001;
Fig. 3); therefore, a neutralizing anti-equine TNF- Mab
was used to confirm that activity detected by WEHI-13var
bioassay in the supernatant of KY84-infected BM was in
fact TNF-. There was marked (95%) neutralization of
the TNF- activity in supernatant that was incubated with
either 10- or 100-fold dilutions of the Mab prior to bioassay,
and partial neutralization (66%) with a 1:1000 dilution of
the Mab (P  0.0001; Fig. 3).
Activation of equine endothelial cells by supernatants of
EAV-infected macrophages and endothelial cells
Equine ECs were activated by exposure to virus-free
supernatants of EAV-infected macrophages and EC cul-
tures, as determined by cell surface expression of E-selectin
(Fig. 4). Surprisingly, the virus-free supernatants of KY84-
and CA95-infected equine AM and BM induced sub-
stantial expression of E-selectin on exposed ECs, whereas,
infection of ECs with partially purified virus and superna-
tants from EAV-infected ECs did not. The supernatants of
both CA95- and KY84-infected BM induced significantly
greater expression of E-selectin on exposed ECs than did
the supernatants of KY84- or CA95-infected AM (P 
0.0001). Furthermore, the virus-free supernatants from both
KY84-infected BM and AM induced significantly
greater E-selectin expression than did the supernatant from
CA95-infected BM and AM at 2 and 4 h.p.i. (P 
0.0001).
Discussion
Many of the clinical manifestations of EVA reflect en-
dothelial injury and increased vascular permeability (Craw-
ford and Henson, 1973; Estes and Cheville, 1970; McCol-
lum et al., 1971). Thus, in an effort to further characterize
the pathogenesis of EVA, we used cultured equine ECs,
AM, and BM to compare the contributions of direct
virus-mediated EC injury and virus-induced, macrophage-
derived cytokines such as TNF- and IL-1 in mediating
EAV-induced vascular injury. The cultured equine ECs and
macrophages used in this study clearly provide a conve-
nient, reproducible, and relevant in vitro model with which
to further evaluate the pathogenesis of EVA.
AM are a site of primary replication of EAV following
respiratory infection of horses (Glaser et al., 1996; Timoney
and McCollum, 1993) and results of the current study
strongly suggest that they may also be an important source
of virus-induced proinflammatory cytokines that contribute
to expression of EVA. Interestingly, however, permissive
infection of EAV apparently did not occur in AM whereas
substantial replication occurred in both ECs and BM. The
apparent resistance of AM to productive replication of
EAV, as compared to the susceptibility of BM, might
reflect further AM differentiation in the lung microenvi-
ronment or, possibly, the functional heterogeneity of differ-
ent macrophage populations (Rutherford et al., 1993).
The virulent KY84 and avirulent CA95 strains of EAV
induced markedly different quantities of proinflammatory
cytokines such as TNF-, IL-1, IL-6, and IL-8 in infected
AM and BM. Furthermore, these differences in cytokine
production correlate with the well-characterized difference
in the virulence to horses of each virus strain (Balasuriya et
al., 2002; McCollum et al., 1984; Patton et al., 1999). High
levels of TNF- and IL-1 can mediate vascular compro-
mise and acute lung injury in septic shock and perhaps virus
diseases such as severe influenza (Kobzik, 1999; Seo et al.,
2002). These cytokines also mediate macrophage activation
and adhesion of neutrophils through upregulation of E-
selectin on ECs, leading to neutrophil accumulation and
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Fig. 2. Transcription of genes (mRNA) encoding proinflammatory cytokines (TNF-, IL-1, IL-6, and IL-8) in EAV-infected AM and BM and
EAV-infected ECs, as determined by TaqMan real-time polymerase chain reaction. Results are from replicate experiments and represent the mean-fold
increase of mRNA encoding each cytokine, as compared to levels in unstimulated controls at each time point. Data were analyzed by repeated measures
one-way ANOVA followed by a post hoc Tukey’s multiple comparison. Mean quantities of mRNA encoding TNF-, IL-1, IL-6, and IL-8 were significantly
increased at every interval after infection of AM and BM with the virulent KY84 strain of EAV, as compared to those infected with the avirulent CA95
strain. Notably, only TNF- and IL-6 were significantly elevated after infection of ECs at 24 h.p.i. with the virulent KY84 strain of EAV, as compared to
those infected with the avirulent CA95 strain.
tissue injury (Cargile et al., 1995; Kobzik, 1999). Our stud-
ies confirm that EAV-induced, macrophage-derived cyto-
kines are clearly capable of inducing E-selectin expression
by equine ECs, and that this cytokine-mediated expression
of E-selectin on equine ECs is considerably more profound
than that induced by virus infection alone. Significantly, the
virulent KY84 strain of EAV was as potent an inducer of
TNF- secretion by AM and BM as LPS, a major initi-
ator of septic shock.
In summary, data from the present study strongly suggest
that virus-induced macrophage-derived proinflammatory
cytokines contribute to the vascular injury and EC activa-
tion that characterize severe EVA. Furthermore, strains of
EAV induce quantities of these cytokines that are reflective
of their individual virulence to horses.
Materials and methods
Viruses
Replication of the virulent KY84 and avirulent CA95
strains of EAV was compared in cultured equine ECs and
macrophages, as was their relative ability to activate these
cells. The KY84 strain of EAV was isolated during an
outbreak of EVA among Thoroughbred horses in Kentucky
in 1984, and the CA95 strain was isolated from the semen
of a persistently infected carrier Standardbred stallion in
California in 1995 (Table 1). The virulence to horses of each
of these virus strains has previously been comprehensively
defined (Balasuriya et al., 2002; McCollum and Timoney,
1984, 1999; Patton et al., 1999). The passage history of
these two viruses previously has been described (Balasuriya
et al., 2002; Patton et al., 1999) and, prior to use in these
studies, each virus was passaged once in rabbit kidney cells
(RK-13; ATCC, Manassas, VA) to prepare a stock as pre-
viously described (Moore et al., 2002). Briefly, RK-13 cells
infected with each virus were frozen at70°C after appear-
ance of cytopathic effect (CPE). Cell lysates were clarified
by low-speed centrifugation (1700 g), followed by ultracen-
trifugation at 121,6000g through a 20% sucrose cushion in
NET buffer (150 mM NaCl, 5 mM EDTA, and 50 mM
Tris–HCl, pH 7.5) at 4°C for 4 h to pellet the virus. Partially
purified preparations of each strain of EAV were resus-
pended in Eagle’s minimal essential medium and frozen at
70°C. The titer of each virus stock was determined as
Fig. 3. Production of TNF- by EAV-infected equine-AM, BM, and ECs, as determined by WEHI-13var bioassay (a). Results are from replicate
experiments and represent the mean increase of TNF- concentrations in culture supernatants at 24 h.p.i. Data were analyzed by repeated measures one-way
ANOVA followed by a post hoc Tukey’s multiple comparison. Amounts of TNF- were significantly higher in AM, BM, and ECs infected with the KY84
strain of EAV, as compared to those infected with the CA95 strain. TNF- activity detected in the supernatant of KY84-infected BM by WEHI-13var
bioassay was neutralized with a neutralizing murine Mab to equine TNF- (b).
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plaque-forming units (PFU) per milliliter in RK-13 cells.
Similar preparations of uninfected RK-13 cells were pre-
pared for mock infections of equine macrophages and ECs.
Isolation and culture of equine macrophages and
endothelial cells
Macrophages were collected from four healthy, adult,
mixed-breed horses. AM were harvested by bronchoal-
veolar lavage (BAL), and BM were isolated and cultured
from anticoagulated blood taken from the same animals, as
previously described (MacKay et al., 1991). Briefly, cells
were harvested using BAL of sedated horses by gravity
instillation and recovery of 250-ml volumes of LPS-free,
0.9% NaCl solution through an 11-mm-diameter BAL cath-
eter (Bivona, Medical Technologies, Gary, IN). Cells in the
aspirated BAL fluid were pelleted by centrifugation at 400g
for 20 min, and washed twice in cold RPMI 1640 (Gibco,
Fig. 4. Flow cytometric quantitation of E-selectin expression on equine ECs infected with the CA95 and KY84 strains of EAV, and on ECs after incubation
with the culture supernatants of ECs, AM, and BM collected at 24 h.p.i. with either the CA95 (a) or the KY84 (b) strain of EAV. Results are from replicate
experiments and represent the mean-fold increase in the incidence of E-selectin on ECs, as compared to unstimulated mock controls. Data were analyzed by
repeated measures one-way ANOVA followed by a post hoc Tukey’s multiple comparison. E-selectin expression was significantly increased in ECs exposed
to culture supernatants from AM and BM infected with the virulent KY84 strain of EAV as compared to those infected with the avirulent CA95 strain,
whereas E-selectin expression was not increased after infection of ECs with either the KY84 or CA95 strains of EAV or after exposure of ECs to the
supernatants of EAV-infected ECs. A variety of inducers of E-selectin expression on ECs (LPS and recombinant TNF- and IL-1) were included as positive
controls (c).
Table 1
Origin, passage history, and virulence to horses of strains of equine arteritis virus (EAV)
Virus State of
origin
Year isolated Horse breeda Cell typeb and
passage history
Severity of clinical disease
in inoculated horses
KY84 Kentucky 1984 TB RK 3 Moderately severec
CA95 California 1995 STD RK 3 Subclinicald
a Horse breeds: TB, Thoroughbred: STD, Standardbred.
b Cells: RK, rabbit kidney 13 followed by the number of passages.
c McCollum and Timoney, 1984: Balasuriya et al., 2002.
d Patton et al., 1999.
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Carlsbad, CA). Cells then were resuspended in complete
RPMI medium [RPMI 1640 w/2 mM L-glutamine, 10%
fetal calf serum (HyClone Laboratories, Inc., Logan, UT),
nonessential amino acids, and antibiotics], plated into six-
well culture plates at 37°C in 5% CO2, and incubated for
2 h, and nonadherent cells were removed by gently washing
the plates three times with warm RPMI. Greater than 95%
of the adherent cells were AM, as determined by differ-
ential staining with Wright Giemsa stain and light micro-
scopic examination. BM were isolated from the buffy coat
of anticoagulated blood collected from individual horses.
Briefly, peripheral blood mononuclear cells (PBMCs) were
isolated by centrifugation of buffy coat cells through His-
topaque-1077 (Sigma, St. Louis, MO). The enriched
PBMCs were washed and pelleted three times, prior to
resuspension in freezing medium (90% fetal bovine serum
plus 10% DMSO) and freezing at 80°C to lyse residual
platelets. The PBMCs were then resuspended in complete
RPMI culture medium and incubated in six-well culture
plates for 2 h at 37°C in 5% CO2 prior to removal of the
nonadherent cells by gentle washing. Approximately 97%
of the adherent PBMCs were BM, as determined by im-
munofluorescence staining and flow cytometric quantitation
using Mabs against CD3 (Mab F6G; Lunn et al., 1998),
CD21 (Mab 30695X; BD PharMingen, San Diego, CA),
and MHC class II antigens (Mab F13A; Lunn et al., 1998).
The isolation and purification of ECs from the pulmo-
nary artery of a foal has been previously described (Hedges
et al., 2001; Moore et al., 2002). The purity of the EC
cultures was confirmed by flow cytometric analysis after
immunofluorescence staining of cells with a panel of Mabs
specific for epithelial and mesothelial cells, pericytes, and
smooth muscle cells, and with rabbit antiserum to von
Willebrand factor, as previously described (Hedges et al.,
2001; Moore et al., 2002). ECs were maintained in endo-
thelial cell maintenance medium (Dulbecco’s modified es-
sential medium with sodium pyruvate; Mediatech, Herndon,
VA), 10% heat-inactivated inactivated fetal bovine serum,
antibiotics, nonessential amino acids, and 200 mM L-glu-
tamine (Sigma). All experiments were performed on EC
cultures between passages 5 and 10.
Replication of EAV in equine macrophages and
endothelial cells
Replication of the CA95 and KY84 strains of EAV was
compared in equine AM, BM, and ECs. BM and AM
(approximately 1.0  106/well) were incubated in six-well
tissue culture plates for 24 h prior to infection at a multi-
plicity of infection (m.o.i.) of 5 with either the KY84 or the
CA95 strain of EAV. Virus was adsorbed for 1 h, and
cultures were then washed three times with RPMI and then
supplemented with complete RPMI medium. Cultures were
incubated at 37°C in 5% CO2 and individual cultures were
harvested at 1, 6, and 12 h and at subsequent 12-h intervals
until 72 h.p.i. Titers of EAV in sonicated culture lysates
were determined by plaque assay on RK-13 cells, as previ-
ously described (McCollum et al., 1962; Moore et al.,
2002). Confluent monolayers of cultured equine ECs also
were infected with the CA95 or KY84 strains of EAV at an
m.o.i. of 5.0, and harvested at 6-h intervals. Control cultures
of each cell type were inoculated only with complete RPMI
(mock-infected).
Transcription of cytokine genes in EAV-infected equine
alveolar macrophages and endothelial cells
TaqMan real-time polymerase chain reaction (PCR) was
used to quantitate the transcription of mRNA encoding
TNF-, IL-1, IL-6, and IL-8, and in lysates of equine ECs,
AM, and BM at 6, 12, 18, and 24 h.p.i. with either the
KY84 or the CA95 strain of EAV. Primers and probes were
designed with the PrimerExpress software package (Ap-
plied Biosystems, Foster City, CA) such that the probe
spanned the junction of two exons covered by the primers,
ensuring discrimination between genomic DNA and cDNA
generated from mRNA (Table 2). Approximately 1  106
equine ECs, AM, and BM were pelleted, washed in
phosphate-buffered saline (PBS), and stored in RNAlater
(Ambion, Austin, TX) at 4°C until further processing. Total
RNA was isolated using the RNAqueous-4PCR kit (Am-
bion) according to the manufacturer’s recommendations.
The extracted RNA was treated with ultrapure DNase 1 and
reversed transcribed with SuperScript II reverse transcrip-
tase (Invitrogen, Carlsbad, CA). The primers, probe, PCR
master-mix, and AmpErase UNG were combined with the
cDNA derived from each sample and amplified in an auto-
mated fluorometer (ABI Prism 7700 sequence detection
system; Applied Biosystems). Quantitation of cytokine
mRNA was determined by the comparative cycle threshold
Table 2
Sequence of PCR primers and TaqMan probes specific for equine
proinflammatory cytokines
Cytokines Primersa Sequences (5–3)
TNF- eTNFa-222f GCCCAGACACTCGATCATCTTC
eTNFa-332r CATTTGCACGCCCACTCA
IL-1 elL1b.7f GCAGTACCCGACACCAGTGA
eIL1b.88r TTTTGGGCCATCCTCCTCA
IL-6 eIL6-478f GTAACCACCCCTGACCCAACT
eIL6-559r TTGTTGTGTTCTTCAGCCACTCA
IL-8 eIL8.160f TGATTGAGAGTGGGCCACACT
eIL8.263r ATAATCTGCACCCACTTTGTATGG
Cytokines Probe Sequences (5–3)
TNF- eTNFa-270p CCCATGTTGTAGCAAACCCCCAAGC
IL-1 elL1b.31p TCATTCTCATTGCCGCTGCAGTAAGTCAT
IL-6 eIL6-510p CCTGCTGGCTAAGCTGCATTCACAGA
IL-8 eIL8.183p CGAAAACTCAGAAATCATTGTAAAGCTC-
GTCAAC
a f, forward primer; r, reverse primer; p, probe label: 6-FAM and
TAMRA quenched.
668 B.D. Moore et al. / Virology 314 (2003) 662–670
(CT) method. Mock-infected equine ECs, AM, and BM
were used as the reference sample (calibrator) at each time
point. The relative change in mRNA concentration (CT)
for each test sample was then determined from the differ-
ence between the calibrator CT and the CT of each test
sample.
E-selectin expression on EAV-infected equine endothelial
cells
E-selectin expression was quantitated at 2, 4, and 6 h
after infection of equine ECs with either the KY84 or the
CA95 strain of EAV, using flow cytometric analyses as
previously described (Hedges et al., 2001). Briefly, ECs
were infected with either the KY84 or the CA95 strain of
EAV at an m.o.i. of 5.0. Expression of E-selectin was
measured by the binding of Mab BBIG-E6 (R & D Systems,
Minneapolis, MN) that is specific for human E- and P-
selectin, and which also identifies equine E-selectin (Hedg-
es et al., 2001). Single-cell suspensions were obtained after
cell scraping with a rubber policeman and repeated pipet-
ting. Cell suspensions were washed in PBS and 0.1% so-
dium azide prior to labeling with Mab BBIG-E6. Cells were
then washed and fixed with 1% paraformaldehyde with
0.1% goat serum in PBS, washed, and labeled with a fluo-
rescein isothiocyanate (FITC)-conjugated secondary anti-
body. All washes and antibody dilutions were performed in
flow buffer [divalent cation-free PBS, 1% normal goat se-
rum, 5 mM ethlyenediaminetetraacetic acid (EDTA), 0.01%
NaN3, pH 7.4]. Data were collected using a FACScan (Bec-
ton–Dickenson, San Jose, CA) at 2, 4, and 6 h.p.i. of equine
ECs. Additional cultures of equine ECs were stimulated
with 10 ng/ml of lipoplysaccharide (LPS; Sigma), recom-
binant IL-1 (BioSource International, Camarillo, CA), and
recombinant TNF- (BioSource International) as positive
controls, as previously described (Hedges et al., 2001).
Mock-infected equine ECs were included as negative con-
trols.
TNF- production in EAV-infected equine macrophages
and endothelial cells
A bioassay was used to quantitate TNF- in the super-
natant of cultured equine ECs, AM, and BM infected
with either the KY84 or the CA95 strain of EAV, as well as
in the supernatant of mock-infected cultures. Ninety-six-
well tissue culture plates were prepared using the TNF--
sensitive cell line WEHI-13var and complete RPMI. The
cells were resuspended in culture medium at a density of 5.0
 105 cells/ml, and 100-l aliquots of the cell suspension
were transferred to each well of a 96-well microplate and
incubated overnight at 37°C in 5% CO2. For TNF- quan-
titation, culture medium was removed from each well and
50 l of the test sample or a TNF- standard was then
added to each well together with actinomycin D (1 g/ml;
Gibco) to sensitize the WEHI-13var cells to the effects of
TNF-. Plates were incubated for 18 to 20 h. Twenty
microliters of combined MTS/PMS (Promega, Madison,
WI) solution was then added, and the plates were further
incubated at 37°C in 5% CO2 for 2 h when the absorbance
at 490 nm was recorded using an ELISA plate reader.
To confirm the authenticity of the cytotoxic factor de-
tected in the WEHI-13var bioassay as TNF-, activity of the
supernatant of a KY84-infected BM culture was deter-
mined after incubation at various dilutions with an anti-
equine TNF--neutralizing Mab (initial concentration 13
g/ml; Cargile et al., 1995).
Activation of equine endothelial cells by macrophage-
derived inflammatory mediators
Lysates of EAV-infected and mock-infected ECs, AM,
and BM were evaluated for their ability to activate equine
ECs, as determined by increased cell surface expression of
E-selectin by EC cultures exposed to the lysates. Cultured
equine ECs, AM, and BM were harvested by freezing at
24 h after infection at an m.o.i. of 5 with either the KY84 or
the CA95 strain of EAV. Cell lysates were clarified by
ultracentrifugation at 121,600g through a 20% sucrose
cushion in NET buffer at 4°C for 4 h to remove EAV from
the preparations, and then stored at 80°C. E-selectin ex-
pression on ECs was determined by flow cytometric anal-
yses at 2, 4, and 6 h after exposure to the same supernatants,
as well as LPS and recombinant IL-1 or TNF-.
Data analysis
Data were analyzed with CELLQuest version 3.1 (Bec-
ton–Dickinson), Excel-97 (Microsoft, Roselle, IL), and
SPSS 11.0 (SPSS Inc., Chicago, IL) software packages.
Experiments were repeated at least twice and the data from
replicate experiments were compared at the time intervals
indicated. The mean values and standard deviations were
calculated for each parameter with repeated measures one-
way ANOVA (parametric analysis of population means) to
determine differences between mean values of the data
collected at each time point. Differences were considered
significant at P  0.05. If the overall ANOVA was signif-
icant, a post hoc Tukey’s multiple comparison of the mean
was performed on data collected from replicate experiments
done at each time point.
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